Hydrogen-rich saline attenuates spinal cord hemisection-induced testicular injury in rats
Ge L, Wei LH, Du CQ, Song GH, Xue YZ, Shi HS, Yang M, Yin XX, Li RT, Wang XE, Wang Z, Song WG. · Oncotarget. 2017;8(26):42314-42331.
Study at a glance
Preclinical
rat, rats, tissue, tissues used to study other neurological conditions.
Full text reports H₂ dissolved in saline. Detected intervention quantities or schedules: 1 week, 6 mL, 6 mL/kg, 0.6 mM. · H₂-related quantities reported in the intervention passages: 1 week, 6 mL, 6 mL/kg, 0.6 mM. Values are not combined across different experimental arms.
1 week
Article-reported result excerpt (24 words maximum): “The BBB score indicated that hSCI caused significant deficit in the hind limb neurological function, which was markedly improved by HS treatment at 3,…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.
Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.
What kind of evidence is this?
Preclinical
Controlled animal and cell study
Other neurological conditions
Other forms
Information not yet classified
Some editorial classification fields are still pending. The source-reported outcomes and result are shown below; Hydrogenology does not infer a positive or negative signal from prose automatically.
Methods
rat, rats, tissue, tissues used to study other neurological conditions.
Preclinical study; group or assay counts reported in the full text include n=9, n=36, n=6.
1 week
Full text reports H₂ dissolved in saline. Detected intervention quantities or schedules: 1 week, 6 mL, 6 mL/kg, 0.6 mM.
H₂ dissolved in saline — H₂ only unless the full text explicitly reports oxygen co-delivery.
H₂-related quantities reported in the intervention passages: 1 week, 6 mL, 6 mL/kg, 0.6 mM. Values are not combined across different experimental arms.
Control or comparison condition reported in the full article; see the linked methods for arm-specific details.
Outcomes and reported result
survival or mortality, clinical symptoms or functional scores, inflammation and cytokines, oxidative-stress and antioxidant markers, apoptosis or cell injury, neurological or behavioral measures
Article-reported result excerpt (24 words maximum): “The BBB score indicated that hSCI caused significant deficit in the hind limb neurological function, which was markedly improved by HS treatment at 3,…” This excerpt is not a complete result summary; consult the linked full text for all positive and null findings.
The complete machine-readable article was checked for source identity, methods, intervention quantities, results, tables, funding and conflict declarations. This public record is based on the full article.
A reported association, difference or mechanism is not automatically a clinical benefit.
Limitations and applicability
Preclinical evidence only; findings do not establish a treatment effect in people. Funding or grant information is reported in the full article. The article declares no conflicts of interest.
Applies to the reported animal, cell or tissue model for other neurological conditions, not directly to patients.
No single-study GRADE certainty rating is assigned. Read how records and evidence assessments are prepared.
Sources and record status
PMID: 28404953 · DOI: 10.18632/oncotarget.15876
A free full article is available through PubMed Central.
Official Europe PMC JATS full article and PubMed/PMC identifiers; structured full-text extraction and validation completed 8 August 2026.
29 September 2026
Help people check the facts before they buy.
Hydrogenology keeps 665 source-checked records accessible without advertising or product promotion.
Help us correct the recordReport a discrepancy
Send the exact difference between this page and the linked source. The study reference is attached automatically.